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Abstract
The coccidia Isospora felis and Isospora rivolta are 
intestinal parasites occurring worldwide in domes-
tic cats. In young cats, they can be detected with 
higher prevalence.
The effects of toltrazuril in the new combination 
product Procox® oral suspension for dogs contain-
ing 0.1 % emodepside and 2 % toltrazuril (0.9 mg 
emodepside + 18 mg toltrazuril per ml) were stud-
ied in eighteen kittens experimentally infected 
each with a total of 1 x 105 oocysts of a mixture 
of Isospora felis and Isospora rivolta. In the infec-
tious material, the quantitative relation of I. felis 
and I. rivolta was about 1:5. Following a three-
days period after infection, two groups of 6 kittens 
were treated during the prepatent period with 
either a single dose of 0.45 mg emodepside + 9 mg 
toltrazuril/kg body weight or 0.9 mg emodepside + 
18 mg toltrazuril/kg body weight. A group of six 
kittens without any treatment served as a con-
trol. On day 5 post infection, the untreated kittens 
started the excretion of oocysts. Treatment with 
both toltrazuril doses significantly reduced oocyst 
excretion. Following the single higher dose, the 
reduction of oocysts of both Isospora spp. was more 
pronounced (96.7 % to 100 %) in comparison to the 
lower dose (57.2 % to 100 %). The Procox® applica-
tion was well tolerated and no adverse events were 
seen with any of the applied dosages.
When administered to kittens and as a single treat-
ment during the prepatent period, Procox® is suit-
able to control the number of oocysts excreted in 





Domestic cats can be the hosts of a number of coc-
cidia species representing various genera, but only 
Toxoplasma gondii and certain species of the genus 
Isospora are associated with clinical disease. The 
enteropathogenic coccidia of the cat are Isospora 
(Cysto isospora) felis (Wenyon 1923) and Isospora 
(Cysto isospora) rivolta (Grassi 1879). Prevalence rates 
from faecal screenings vary significantly depending 
on the Isospora species, the age group and the liv-
ing conditions of the cats (Kirkpatrick 1987). Araujo 
(1996) detected Isospora oocysts in 10 % of feline 
faecal samples in Brazil. In Germany, Barutzki and 
Schaper (2003) found Isospora oocysts in 21.9 %, and 
Epe et al. (2004) in 10.7 % of feline faecal samples. 
Particularly heavy infections can occur in kittens 
kept in commercial breeding colonies when hygiene 
is poor and this may result in diarrhoea (Battersby 
and Harvey 2006). A comparison of the prevalence of 
gastrointestinal parasites from well-cared and ani-
mal shelter cats in Australia showed that I. felis was 
present in 1.7 % of the well-cared cats and in 10.2 % 
of the animal shelter cats (Palmer et al. 2008). Young 
kittens less than 6 months of age had higher rates of 
oocyst shedding (Lopez et al. 2006).
Pathogenicity of the two feline Isospora species is 
discussed controversely. There is agreement about 
the fact that most infections are mild or subclinical, 
especially in adult cats. However, in some cases, 
the parasitosis can be more severe, particularly 
when complicated by other disease-causing agents, 
or in very young kittens and in debilitated animals. 
In these cases, haemorrhagic enteritis, dehydra-
tion, anaemia, anorexia, weight loss and emesis 
can occur (Dubey 1993; Tzannes et al. 2008). In 
young kittens, clinical cases often manifest after 
the kitten has been moved, for instance, to a new 
home, suggesting that stress factors may be neces-
sary for disease outbreak (Lindsay et al. 1997). In 
older cats, the infection can also occur when the 
cats are immunocompromised (Levine 1973).
There are two routes of infection. The oral ingestion 
of Isospora cysts in tissues of intermediate hosts 
will result in intestinal infection in cats. The oral 
ingestion of sporulated (but not  unsporulated) Isos-
pora oocysts by cats from faeces of other cats will 
also establish infection. There is no evidence for 
congenital transmission, but kittens may become 
infected early in life from faecal shedding by lactat-
ing queens (Dubey 1977).
Isospora rivolta (I. rivolta) develops in the entero-
cytes of the small intestine (Dubey 1979). Under 
experimental conditions, I. rivolta caused dis-
ease in newborn kittens (Dubey 1979). Diarrhoea 
occurred 3 – 4 days after administration of 1 x 
105 or 1 x 106 sporulated oocysts. No disease was 
observed in 10- to 13-weeks-old kittens inoculated 
with up to 105 oocysts (Dubey 1979). Cats devel-
oped immunity to infection, but it was not com-
plete as some oocysts were shed after challenge 
(Dubey 1979).
Isospora felis (I. felis) develops in the enterocytes of 
the small intestine and occasionally in the caecum 
(Shah 1971). Experimental studies indicate that 
I. felis is non-pathogenic for cats over 1 month of 
age (Shah 1971). Few signs of disease were seen in 
6- to 13-weeks-old kittens when given 1 x 105 to 
1.5 x 105 oocysts. Four-weeks-old kittens seemed 
to be the most susceptible, as enteritis and ema-
ciation occurred after inoculation of 1 x 105 oocysts 
(Andrews 1926). A comparison of feline Isospora 
species is shown in Tab. 1.
Procox® oral suspension for dogs is a new oral sus-
pension containing a combination of the nematocid-
al and coccidiocidal active principles emodepside 
(0.1 %) and toltrazuril (2 %). It is approved for the 
treatment of puppies and young dogs with suspect-
ed or confirmed mixed infections caused by round-
worms (Toxocara canis, Uncinaria stenocephala, 
Ancylostoma caninum) and Isospora (Isospora 
canis, Isospora ohioensis-complex).
Beside the indications listed for the combination 
product Procox®, the coccidiocidal active toltrazuril 
has been proven to be effective against Eimeria 
infections in poultry and, more recently, against 
coccidiosis in sheep, rabbits, piglets and calves 
(Haberkorn 1996; Mundt et al. 2006; Gjerde et al. 
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2009). For these animal species, toltrazuril is avail-
able as oral solution to be mixed with drinking 
water or oral suspension for direct oral application 
under the brand Baycox®.
Besides, there have been some reports that 
toltrazuril reduces Isospora species oocyst counts 
in man and cats (Kayembe 1989; Cieslicki et al. 
1993; Lloyd and Smith 2001; O’Brien 2002). Both, 
Lloyd and Smith (2001) and O’Brien (2002) used 
treatment with toltrazuril (Baycox®) against nat-
ural Isosopora infections in kittens suffering from 
vomiting and diarrhoea as an empiric therapy. In 
both cases, rapid improvement of clinical signs 
and suppression of oocyst excretion was observed 
using different dose regimens and treatment 
durations.
The availability of the new combination product 
for puppies and the successful treatment described 
by Lloyd and Smith (2001) and O’Brien (2002) was 
a justification to test Procox® under experimental 
conditions in kittens against the two enteropath-




This study was performed as a negative control-
led, randomised and non-blinded efficacy study 
against mixed prepatent infections with I. felis and 
I. rivolta, and it was conducted as a dose determi-
nation study. The study design is summarised in 
Tab. 2. 
Study animals
The kittens used in this study were purpose-bred 
animals that had not been treated previously with 
anthelmintic or anticoocidial drugs. Eighteen kit-
tens were acclimatised to the study facility for at 
least 7 days prior to the start of the study. They 
were identified by ear tattoo number. At study 
start kittens were 12 weeks of age, and the body 
weight ranged between 1.0 and 1.3 kg. Until the 3rd 
day post infection (dpi), the kittens were housed in 
groups of two kittens each, and thereafter kittens 
were housed separately for the subsequent study 
period. The kittens were fed with commercially 
available dry kitten food once daily and water was 
available ad libitum. 
General requirements for study inclusion were good 
health as determined by a veterinary examination 
Tab. 1   Comparison of the life cycles of feline Isospora species and description of oocysts 
(Shah 1971; Dubey 1979, Lindsay 1990)


















before study start and repeated negative faecal 
oocyst counts (FOC) for Isospora felis and Isospora 
rivolta before experimental infection.
Clinical observations
The health status of all kittens was assessed once 
before treatment and 2, 4 and 24 hours after treat-
ment, and thereafter once daily. The kittens were 
evaluated for general attitude and behaviour, and 
faecal consistency was assessed. 
Experimental infection
All kittens were infected orally with sporulated 
oocysts from Isospora felis and Isospora rivolta at 
an 1:5 ratio. The oocysts had been derived from an 
isolate originally obtained from naturally infected 
cats from an animal shelter in North Rhine-West-
phalia. The isolate was purified and then stored in 
2 % potassium dichromate until the day of infec-
tion. Oocysts were seven weeks old. At the day 
of infection, the oocysts were concentrated and 
washed by repeated centrifugation and con trolled 
for sporulation. On day 0, individual inocula of 
1 x 105 oocysts were prepared and administered to 
each of the eighteen kittens as a single oral dose.
Treatment
At day 0, the kittens were ranked according to their 
body weights and they were randomly allocated to 
the groups. At 3rd dpi, kittens of group 1 and 2 were 
treated with Procox® oral suspension for dogs at 
a dosage of 0.5 ml/kg body weight (group 1) and 
1.0 ml/kg body weight (group 2) corresponding to 
0.45 mg emodepside + 9.0 mg toltrazuril per kg 
body weight and 0.9 mg emodepside + 18.0 mg 
toltrazuril per kg body weight, respectively. Kittens 
of the control group were left untreated. The indi-
vidual doses were based on the body weights taken 
on the day of treatment. The single treatment was 
performed orally. The kittens were observed after 
dosing to determine whether any suspension was 
regurgitated. 
Parasitological techniques
Before the start of the experimental infection, FOC 
were performed on grouped faecal samples from two 
kittens each to determine whether  natural Isospora 
infections were present (day –11 to day – 6). On 
day 0, a faecal sample was collected from each indi-
vidual kitten before experimental infection. From 
5th dpi onwards, individual FOC were performed 
daily to detect the possible beginning of patency. 
FOC were conducted using a modified McMaster 
method (Schmidt 1971; Wetzel 1951). Adequacy of 
Isospora infection in the control group was assessed 
per study day. The control group was considered to 
be adequately infected on days with positive oocysts 
counts in all 6 control animals. Results are present-
ed as number of oocysts per gram faeces (OPG).
Efficacy calculation
The criterion for effectiveness of the Procox® oral 
suspension for dogs was the post treatment OPG 
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untreated control group. The efficacy of the treat-
ment as seen by a reduction of OPG was evaluated 
from 5th dpi onwards for each day in accordance to 
the following formula:
% Effectiveness (reduction) = (N2 – N1) x 100
 N2
N1:   geometric mean OPG of I. felis/I. rivolta for the 
treated group (group 1 and 2)
N2:   geometric mean OPG of I. felis/I. rivolta for the un-
treated control group (group 3)
Statistical significant differences between arithme-
tic mean number of excreted oocysts of the treat-
ment groups and of the control were examined by 
One-way ANOVA with Bonferroni’s Multiple Com-
parison post test using the programme GraphPad 
Prism (version 5.00 for Windows, GraphPad Soft-
ware, San Diego, CA, USA, www.graphpad.com).
Results
Repeated faecal examinations showing negative 
OPG before experimental infection confirmed the 
absence of natural Isospora infections in all kittens.
The success of the experimental infection with 
Isospora oocysts was demonstrated by considerable 
numbers of both I. felis and I. rivolta oocysts in 
faecal samples from all six kittens of the  untreated 
control, starting 6 dpi until 14 dpi with two peak 
oocyst excretions on days 7/8 and day 12 and declin-
ing OPG on 14 dpi.
Treatment with the single dose 9.0 mg toltrazuril/
kg body weight in group 1 significantly reduced 
oocyst counts from day 6 – 8 dpi and day 12 – 13 dpi 
(p < 0.001) (> 99 % efficacy). Oocyst counts were 
markedly but not significantly reduced in group 
1 on day 9 and 10 dpi (Fig. 1). Oocyst count reduc-
tion from the single 18.0 mg toltra zuril/kg body 
weight dose in group 2 showed significant differ-
ences (from p < 0.01 to p < 0.001) from day 7 dpi 
until day 13 dpi (> 99 % efficacy) (Tab. 3 and Fig. 1). 
As the OPG declined on day 14 dpi in the control 
cats, no significant differences in the oocyst excre-
tion between treated and untreated cats could be 
detected on this day. 
Although a successful infection could be established, 
no clinical signs of coccidiosis like diarrhoea or eme-
sis were observed in any of the kittens during the 
observation period. The Procox® oral suspension was 
highly palatable and well accepted by the kittens. 
No regurgitation was observed. In both dose groups, 
no adverse reactions due to Procox® treatment were 
observed during the post treatment interval. 
Discussion
The present study demonstrated that a single oral 
administration of 1 x 105 I. felis/I. rivolta oocysts in 
12-weeks-old kittens resulted in a successful infec-
tion with distinct oocyst shedding in all kittens of 
the untreated control group starting on 6th dpi. 
This is consistent with data from the literature 
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stating a prepatent period of 4 – 7 days for I. rivolta 
and 7 – 11 days for I. felis.
This study also proved that kittens with Isospora 
felis/Isospora rivolta infections usually manifest 
no clinical signs of coccidiosis, such as diarrhoea, 
vomiting, lethargy or weight loss as in none of the 
kittens of the control group any abnormal clini-
cal signs were seen. As described in studies with 
Isospora suis infections in pigs where oocyst shed-
ding was the most reliable objective variable of 
infection (Mundt et al. 2006), faecal oocyst counts 
were therefore chosen to be the primary criterion 
for efficacy in this study. 
Re-infections and development of immunity have a 
great influence on the course of oocyst shedding. In 
order to evaluate efficacy of a product, the choice of 
length of the study period  between the treatment 
day and the end of the examination period is of 
decisive importance, as with increasing duration 
of the examination period the distinction between 
treatment response and development of immuni-
ty or re-infections becomes increasingly difficult. 
Based on this experience a study design with a 
14 days observation period was chosen to minimise 
the effects of these interference factors.
Starting at 6 dpi, both toltrazuril doses induced 
a rapid reduction in oocyst excretion. However, a 
more pronounced suppression of oocyst excretion 
was observed in the higher toltrazuril dose group.
The Procox® application was well tolerated and no 
adverse events were seen with any of the applied 
dosages. 
In cases with suspected or confirmed coccidiosis in 
cats and especially in very young kittens, Procox® 
will be a suitable treatment during the prepatent 
period by reducing the contamination of litters with 
Isospora oocysts. Especially in animal shelters or 
large catteries with a high Isospora infection pres-
sure, this will be an effective measure to reduce 
or even to prevent problems due to intestinal coc-
cidiosis, as it has already been demonstrated for 
puppies (Daugschies et al. 2000).
It has been clearly shown that Procox® oral sus-
pension for dogs is effective against Isospora felis/
Isosopora rivolta infections in kittens under experi-
mental conditions.
9.0 mg toltrazuril/kg b.w.
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The efficacy, safety and high palatability of the 
Procox® oral suspension offers a suitable treatment 
option for kittens affected by coccidiosis.
Compliance statement 
All of the studies reported herein were performed in 
compliance with current, applicable, local laws and 
regulations. The study was conducted in accord-
ance with the standards of Good Scientific Prac-
tice studies and followed the requirements given 
in the VICH guideline 7 “Efficacy requirements for 
anthelmintics: General requirements” (December 
2000). All animal procedures were approved by 
the responsible authorities and the animal welfare 
officer. Husbandry of animals complied with the 
European Commission guidelines for the accommo-
dation of animals used for experimental and other 
scientific purposes (June 18 2007/526/EC).
Disclosure statement
The study was sponsored by Bayer Animal Health 
GmbH, all authors were employed by Bayer Ani-
mal Health GmbH, Germany, during the conduct 
of this study.
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